Korea/Asia, Events, IPOs, Douglas Research Advisory

Douglas Kim

Korea/Asia, Events, IPOs

Equity Capital Markets

<p><a href="https://www.cmlviz.com/stocks/LDOC" target="_blank" rel="noopener">LinkDoc Technology</a> plans to offer 10.8 million ADS shares priced at between $17.50 And $19.50 per ADS. If the underwriters exercise their option, there will be 12.45 million shares of ADS. At the high end of the IPO price range, the company will raise $243 million, which is lower than the $500 million that was expected to be raised as mentioned in the media in the past several weeks. This is a reflection of the volatile Chinese IPO environment in 2021.</p><p><a href="https://www.cmlviz.com/stocks/LDOC/news/b/2021/07/01/linkdoc-technology-ltd-sees-u-s-ipo-of-10-8-mln-adss-expected-to-be-priced-between-17-50-and-19-50-per-ads---filing" target="_blank" rel="noopener">Alibaba Health</a>, Lake Bleu Prime Healthcare Master Fund, and UBS Asset Management have indicated to buy about $25 million each of ADS in this IPO at the IPO price. </p><div class="content-highlight">
<p>Our base case valuation of LinkDoc Technology suggests an implied market cap of $2.0 billion or $22.3 per share. At the mid point of the IPO price range ($18.5), our base case valuation suggests a 20% upside. Given the moderate upside, we have a Positive rating on this IPO.</p>
<p>Our base case valuation is based on 7.0x EV/S using our estimated sales of 1,827 million RMB. Our base case valuation multiple of 7.0x EV/S is based on a 20% discount to the comps' average EV/S multiple in 2022. We used a 20% discount to the comps' average valuation multiple mainly due to lower expected sales and lower operating margins for LinkDoc versus the comps.</p>
</div>

LinkDoc Technology plans to offer 10.8 million ADS shares priced at between $17.50 And $19.50 per ADS. If the underwriters exercise their option, there will be 12.45 million shares of ADS. At the high end of the IPO price range, the company will raise $243 million, which is lower than the $500 million that was expected to be raised as mentioned in the media in the past several weeks. This is a reflection of the volatile Chinese IPO environment in 2021.Alibaba Health, Lake Bleu Prime Healthcare Master Fund, and UBS Asset Management have indicated to buy about $25 million each of ADS in this IPO at the IPO price. 
Our base case valuation of LinkDoc Technology suggests an implied market cap of $2.0 billion or $22.3 per share. At the mid point of the IPO price range ($18.5), our base case valuation suggests a 20% upside. Given the moderate upside, we have a Positive rating on this IPO.
Our base case valuation is based on 7.0x EV/S using our estimated sales of 1,827 million RMB. Our base case valuation multiple of 7.0x EV/S is based on a 20% discount to the comps' average EV/S multiple in 2022. We used a 20% discount to the comps' average valuation multiple mainly due to lower expected sales and lower operating margins for LinkDoc versus the comps.


LinkDoc Technology IPO Valuation Analysis

IPOs and Catalysts/Events, Global Equity Research Ltd

Arun George

IPOs and Catalysts/Events

Uncompromised, Independent, Conflict-Free Research

Global Equity Research Ltd

Global Equity Research was started in 2017 by a group of experienced research professionals. It was founded on a passionate belief in the importance and the need for uncompromised, independent, conflict-free research. We aim to provide differentiated and actionable primary and bottom up fundamental research.

<div>
<a href="https://www.smartkarma.com/entities/linkdoc-technology-limited" target="_blank" data-smartkarma-citation="entities:33499:1" rel="noopener">LinkDoc (LDOC US)</a> is a Chinese healthtech company. LinkDoc consists of LinkCare, a digital care platform for patients with critical diseases, LinkData, an AI-enabled curation system for longitudinal medical data, and LinkSolutions, a data-driven precision life sciences solution platform that helps life sciences companies accelerate clinical research and real-world adoption.</div><div></div><p>LinkDoc is backed by Temasek (11.7% of outstanding shares), NEA Partners (10.2%), China Broadband Capital (9.2%), <a href="https://www.smartkarma.com/entities/alibaba-health-information-technology-ltd" target="_blank" data-smartkarma-citation="entities:453:1" rel="noopener">Alibaba Health Information Technology (241 HK)</a> (8.4%) and MBK Partners (6.3%).</p><div><p>At the mid-point of the proposed IPO price range of $17.50-19.50 per ADS, LinkDoc will have a market cap of $1.6 billion. At the mid-point of the IPO price range, the net proceeds are $182.7 million, below the rumoured $500 million raise target. LinkDoc has received $115 million indications of interest (57.4% of the ADSs being offered) from existing shareholders (Alibaba Health, Lake Bleu, Temasek) worth $60 million and new investors (UBS Asset Management, Hudson Bay, Sage Partners) worth $55 million. </p></div><div><p>In <a href="https://www.smartkarma.com/insights/linkdoc-technology-ipo-initiation-building-with-big-data" target="_blank" data-smartkarma-citation="insights:53384" rel="noopener">LinkDoc Technology IPO Initiation: Building with Big Data</a>, we opined that LinkDoc is a play on China’s healthcare industry rising spend on IT and data services. LinkDoc focuses on oncology and has established the largest online oncology physician and patient engagement community in China. LinkDoc is benefiting from the trend of big data solutions adoption in healthcare by delivering solid growth and steadily reducing loss margins. Overall, we believe that LinkDoc is an attractive play on these market dynamics.</p></div><div>
<div class="content-highlight"><p>Our relative valuation analysis suggests that LinkDoc is fairly valued at the low-end of the IPO price range. Consequently, we are inclined to sit on the sidelines awaiting a more attractive entry point.   </p></div>
<div><p><strong><em>For readers interested in IPOs of upcoming healthtech companies, we highlight: </em></strong></p></div>
<div>
<p><a href="https://www.smartkarma.com/insights/medlive-technology-ipo-initiation-what-s-up-doc" target="_blank" data-smartkarma-citation="insights:53683" rel="noopener">Medlive Technology IPO Initiation: What's Up, Doc?</a> </p>
<p><a href="https://www.smartkarma.com/insights/medlive-technology-ipo-valuation-insights" target="_blank" data-smartkarma-citation="insights:53879" rel="noopener">Medlive Technology IPO: Valuation Insights</a> </p>
</div>
<div><p><a href="https://www.smartkarma.com/insights/we-doctor-ipo-initiation-patient-revolution" target="_blank" data-smartkarma-citation="insights:50009" rel="noopener">We Doctor IPO Initiation: Patient Revolution</a> </p></div>
</div>


LinkDoc (LDOC US) is a Chinese healthtech company. LinkDoc consists of LinkCare, a digital care platform for patients with critical diseases, LinkData, an AI-enabled curation system for longitudinal medical data, and LinkSolutions, a data-driven precision life sciences solution platform that helps life sciences companies accelerate clinical research and real-world adoption.LinkDoc is backed by Temasek (11.7% of outstanding shares), NEA Partners (10.2%), China Broadband Capital (9.2%), Alibaba Health Information Technology (241 HK) (8.4%) and MBK Partners (6.3%).At the mid-point of the proposed IPO price range of $17.50-19.50 per ADS, LinkDoc will have a market cap of $1.6 billion. At the mid-point of the IPO price range, the net proceeds are $182.7 million, below the rumoured $500 million raise target. LinkDoc has received $115 million indications of interest (57.4% of the ADSs being offered) from existing shareholders (Alibaba Health, Lake Bleu, Temasek) worth $60 million and new investors (UBS Asset Management, Hudson Bay, Sage Partners) worth $55 million. In LinkDoc Technology IPO Initiation: Building with Big Data, we opined that LinkDoc is a play on China’s healthcare industry rising spend on IT and data services. LinkDoc focuses on oncology and has established the largest online oncology physician and patient engagement community in China. LinkDoc is benefiting from the trend of big data solutions adoption in healthcare by delivering solid growth and steadily reducing loss margins. Overall, we believe that LinkDoc is an attractive play on these market dynamics.
Our relative valuation analysis suggests that LinkDoc is fairly valued at the low-end of the IPO price range. Consequently, we are inclined to sit on the sidelines awaiting a more attractive entry point.   
For readers interested in IPOs of upcoming healthtech companies, we highlight: 

Medlive Technology IPO Initiation: What's Up, Doc? 
Medlive Technology IPO: Valuation Insights 

We Doctor IPO Initiation: Patient Revolution 


LinkDoc Technology IPO: Valuation Insights

APAC IPOs & Placements

Zhen Zhou, Toh

IPOs and Placements coverage across Asia Pacific

Aequitas Research

We cover all listing across the Asia Pacific along with follow-up placements. As of Dec 2020, our team had covered 539 IPOs with a hit rate of 73.5% and 685 placements with a hit rate of 66.8%.

We combine fundamental bottom-up views with our proprietary quantitative framework to provide a holistic coverage across new listings and placements. Our coverage includes pre-IPO notes before the deal is launched, follow-up analysis once the deal is live and post-listing trading analysis as well.

<div><p><a href="https://www.smartkarma.com/entities/linkdoc-technology-limited" target="_blank" data-smartkarma-citation="entities:33499:1" rel="noopener">LinkDoc (LDOC US)</a> is looking to raise about US$500m in its upcoming U.S. IPO.</p></div><div><p>LinkDoc is a data-driven and AI-enabled healthcare technology company. The company operates data-driven digital infrastructures to serve different stakeholders in the healthcare ecosystem. The company has a focus on oncology with its patient care centres providing oncology patients with continuous care.</p></div><div><p>In this note, we look at LinkDoc’s SOTP valuation. </p></div><div><p>We have previously covered the IPO in: </p></div><div><ul>
<li>
<a href="https://www.smartkarma.com/insights/linkdoc-pre-ipo-intricately-embedded-in-the-oncology-industry" target="_blank" data-smartkarma-citation="insights:53324" rel="noopener">LinkDoc (零氪科技) Pre-IPO - Intricately Embedded in the Oncology Industry</a> </li>
<li>
<a href="https://www.smartkarma.com/insights/linkdoc-pre-ipo-peer-comparison-a-niche-that-doesn-t-give-a-clear-advantage" target="_blank" data-smartkarma-citation="insights:53723" rel="noopener">LinkDoc (零氪科技) Pre-IPO - Peer Comparison - A Niche that Doesn’t Give a Clear Advantage</a> </li>
</ul></div>

LinkDoc (LDOC US) is looking to raise about US$500m in its upcoming U.S. IPO.LinkDoc is a data-driven and AI-enabled healthcare technology company. The company operates data-driven digital infrastructures to serve different stakeholders in the healthcare ecosystem. The company has a focus on oncology with its patient care centres providing oncology patients with continuous care.In this note, we look at LinkDoc’s SOTP valuation. We have previously covered the IPO in: 

LinkDoc (零氪科技) Pre-IPO - Intricately Embedded in the Oncology Industry 

LinkDoc (零氪科技) Pre-IPO - Peer Comparison - A Niche that Doesn’t Give a Clear Advantage 


LinkDoc (零氪科技) Pre-IPO - Thoughts on Valuation

<div>
<p><a href="https://www.smartkarma.com/entities/nayuki-holdings" target="_blank" data-smartkarma-citation="entities:32149:1" rel="noopener">Nayuki Holdings (NYK HK)</a> raised US$656m at HK$19.80 per share, the top-end of its IPO price range.</p>
</div>
<div>
<p>Nayuki is the operator of Nayuki teahouses, a premium modern teahouse chain in China. The company had a network of 491 Nayuki teahouses across 61 cities in China as of December 2020. As per CIC, Nayuki is the most extensive premium modern teahouse network in China in terms of the number of cities covered.</p>
<p>In this note, we will discuss deal dynamics and update valuation.</p>
</div>
<div>
<p>We had previously covered the IPO in:</p>
</div>
<div>
<ul style="list-style-type: disc;">
<li>
<a href="https://www.smartkarma.com/insights/nayuki-pre-ipo-fast-growing-cash-flow-positive-teahouse-chain" target="_blank" data-smartkarma-citation="insights:49798" rel="noopener">Nayuki (奈雪) Pre-IPO - Fast-Growing, Cash Flow Positive Teahouse Chain</a> </li>
<li>
<a href="https://www.smartkarma.com/insights/nayuki-pre-ipo-phip-updates-4q20-results-shows-improvement" target="_blank" data-smartkarma-citation="insights:52793" rel="noopener">Nayuki (奈雪) Pre-IPO - PHIP Updates - 4Q20 Results Shows Improvement</a> </li>
<li>
<a href="https://www.smartkarma.com/insights/nayuki-pre-ipo-industry-landscape-and-peer-comparison" target="_blank" data-smartkarma-citation="insights:52797" rel="noopener">Nayuki (奈雪) Pre-IPO - Industry Landscape and Peer Comparison</a> </li>
<li>
<a href="https://www.smartkarma.com/insights/nayuki-pre-ipo-forecast-and-thoughts-on-valuation" target="_blank" data-smartkarma-citation="insights:52992" rel="noopener">Nayuki (奈雪) Pre-IPO - Forecast and Thoughts on Valuation</a> </li>
<li>
<a href="https://www.smartkarma.com/insights/nayuki-ipo-not-cheap-but-should-still-do-well" target="_blank" data-smartkarma-citation="insights:53247" rel="noopener">Nayuki (奈雪) IPO - Not Cheap but Should Still Do Well</a> </li>
</ul>
</div>


Nayuki Holdings (NYK HK) raised US$656m at HK$19.80 per share, the top-end of its IPO price range.


Nayuki is the operator of Nayuki teahouses, a premium modern teahouse chain in China. The company had a network of 491 Nayuki teahouses across 61 cities in China as of December 2020. As per CIC, Nayuki is the most extensive premium modern teahouse network in China in terms of the number of cities covered.
In this note, we will discuss deal dynamics and update valuation.


We had previously covered the IPO in:




Nayuki (奈雪) Pre-IPO - Fast-Growing, Cash Flow Positive Teahouse Chain 

Nayuki (奈雪) Pre-IPO - PHIP Updates - 4Q20 Results Shows Improvement 

Nayuki (奈雪) Pre-IPO - Industry Landscape and Peer Comparison 

Nayuki (奈雪) Pre-IPO - Forecast and Thoughts on Valuation 

Nayuki (奈雪) IPO - Not Cheap but Should Still Do Well 



Nayuki (奈雪) IPO Trading - Good Demand

<p><a href="https://www.smartkarma.com/entities/linkdoc-technology-limited" target="_blank" data-smartkarma-citation="entities:33499:1" rel="noopener">LinkDoc (LDOC US)</a> is looking to raise about US$500m in its upcoming U.S. IPO.</p><p>LinkDoc is a data-driven and AI-enabled healthcare technology company. The company operates data-driven digital infrastructures to serve different stakeholders in the healthcare ecosystem. The company has a focus on oncology with its patient care centres providing oncology patients with continuous care.</p><p>In this note, we compare LinkDoc to other China healthcare companies.</p><p>We have previously covered the IPO in: </p><ul><li dir="ltr" aria-level="1"><p><a href="https://www.smartkarma.com/insights/linkdoc-pre-ipo-intricately-embedded-in-the-oncology-industry" target="_blank" data-smartkarma-citation="insights:53324" rel="noopener">LinkDoc (零氪科技) Pre-IPO - Intricately Embedded in the Oncology Industry</a> </p></li></ul>

LinkDoc (LDOC US) is looking to raise about US$500m in its upcoming U.S. IPO.LinkDoc is a data-driven and AI-enabled healthcare technology company. The company operates data-driven digital infrastructures to serve different stakeholders in the healthcare ecosystem. The company has a focus on oncology with its patient care centres providing oncology patients with continuous care.In this note, we compare LinkDoc to other China healthcare companies.We have previously covered the IPO in: LinkDoc (零氪科技) Pre-IPO - Intricately Embedded in the Oncology Industry 

LinkDoc (零氪科技) Pre-IPO - Peer Comparison - A Niche that Doesn’t Give a Clear Advantage

China

Shanghai Hi-tech Control System Co. Ltd. designs, manufactures, distributes, and provides industrial automation, electric systems, electronic and IT system integration products and services.

Daheng New Epoch Technology Inc. produces network storage products, designs virtual reality software, and provides system integration services.  The Company also designs, develops, and manufactures fine films used in the fiber-optics application, laser processed false proof packaging materials, radiotherapy equipment, and television digital network editing and broadcast system.

Daheng New Epoch Technology, Inc (600288 CH)

United Electronics Company Limited provides data centers of large and medium enterprises with system integration and related technical services. The Company's main products include system integration and technical services.

Wiscom System Co., Ltd. provides software technology, design and consulting services to power-generating enterprises. The company also researches, develops and markets information technology products for colleges and universities.

Guangdong Eastone Century Technology Company Limited provides communication network technology services and system solutions. The Company's main services include technical services such as communication network construction, maintenance and optimization, business support and IT applications related system solutions.

Beijing Trust & Far Technology Company Limited provides IT operational and maintenance services.  The Company's main products include IT infrastructure services, development and sales of IT infrastructure management software, and integration systems and services.

Beijing Transtrue Technology Inc. provides integrated multimedia video solutions. The Company offers a range of services, including consulting design, development, integration and services.

Vixtel Technologies Holdings Limited is an holding company. The Company, through its subsidiaries, are principally engaged in providing application and network performance management and monitoring solutions. Vixtel Technologies Holdings serves customers in the People's Republic of China.

Beijing Teamsun Technology Co., Ltd. develops system integration service for the telecommunication and finance industry. The Company also provides consulting services and markets its product under brand name Teamsun.

Beijing Teamsun Technology Co, Ltd. (600410 CH)

Anhui Wantong Technology Co Ltd. develops information technology software and integration system for highways and provides maintenance services.  The Company also designs, installs and repairs video monitoring network, communication system, and control system.

Comture Corp offers groupware solution and web solution which provides information sharing environments. The Company offers ERP solution services as well as provides network management services.

TDC SOFTWARE ENGINEERING Inc. provides system development services including consultation, installation, operation, and maintenance of the system.  The Company develops network software, and also business management software for such industries as manufacturing, distribution, finance, and retail.  TDC also sells packaged software and hardware products.

Hinduja Global Solutions Ltd. offers business process outsourcing and contact center services.

Cigniti Technologies Ltd. offers information technology services. The Company offers software product testing; performance testing; test automation; mobile testing; test, management and network consulting; and software for organization information, technical  evaluations, and employee management applications.

CMC Corporation manufactures computers.  The Company produces desktop and laptop computers and servers.  CMC also offers systems integration services.

SNP Schneider-Neureither & Partner AG provides software and software related services for the business landscape transformation. The Company's software is used by businesses to implement changes to their IT landscape, business processes and structures. SNP also offer consulting services.

Snp Schneider-Neureither & Partner Ag (SHF GY)

Cafe24 Corp. provides electronic commerce services. The Company offers web hosting, server hosting, e-commerce hosting, e-commerce marketing consulting, and other web services. Cafe24 provides services worldwide.

JBCC Holdings Inc. is a domestic distributor of IBM Japan's hardware and software.  The Company designs, constructs, introduces, operates, and maintains information systems for its customers.  JBCC also provides system solutions.

ZUKEN INC. plans, develops, and sells computer-aided design (CAD), computeraided manufacturing (CAM), and computer-aided engineering (CAE) system services. The Company operates an overseas production subsidiary in England and sales subsidiaries in the US, England, the Netherlands, Germany, Austria, Switzerland, France, Italy, Korea, and Singapore.

Cass Information Systems, Inc. provides freight and utility invoice payment services to Fortune 500 and major logistics companies across North America.  The Company also provides specialized banking services to privately held companies in St. Louis, Missouri, and to churches throughout the United States.

Chinese big data and AI-powered healthcare solutions provider.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Yidu Tech Inc (2158 HK)

LinkDoc Technology IPO Valuation Analysis

Our base case valuation of LinkDoc Technology suggests an implied market cap of $2.0 billion or $22.3 per share, which represents 20% upside from...

Douglas Kim

LinkDoc Technology IPO: Valuation Insights

Our valuation analysis suggests that LinkDoc is fairly valued at the low-end of the IPO price range. Consequently, we are inclined to sit on the...

Arun George

LinkDoc (零氪科技) Pre-IPO - Thoughts on Valuation

LinkDoc is looking to raise about US$500m in its upcoming U.S. IPO.LinkDoc is a data-driven and AI-enabled healthcare technology company.

Zhen Zhou, Toh

Nayuki (奈雪) IPO Trading - Good Demand

Nayuki Holdings (NYK HK) raised US$656m at HK$19.80 per share, the top-end of its IPO price range. Nayuki is the operator of Nayuki teahouses, a...

Zhen Zhou, Toh

LinkDoc (零氪科技) Pre-IPO - Peer Comparison - A Niche that Doesn’t Give a Clear Advantage

LinkDoc (LDOC US) is looking to raise about US$500m in its upcoming U.S. IPO. LinkDoc is a data-driven and AI-enabled healthcare technology company.

Zhen Zhou, Toh

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)